Paper Details
- Home
- Paper Details
Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis.
Author: AkibaTakashi, AokiTakanao, MajimaKazuhiro, NiheiHiroshi, NittaKosaku, SuzukiKoichi, UchidaKeiko, WatanabeRyo-Ichiro
Original Abstract of the Article :
Coronary artery calcification (CAC) is thought to be associated with greater cardiovascular mortality in patients with end-stage renal disease than in nonuremic persons. The purpose of the present study is to assess the effects of etidronate, a synthetic analogue of pyrophosphate, on progression of ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/15384019
データ提供:米国国立医学図書館(NLM)
Etidronate: A Potential Solution for Coronary Artery Calcification in Dialysis Patients
Cardiovascular disease is a major concern for patients undergoing long-term hemodialysis. This research explores the potential of etidronate, a synthetic pyrophosphate analogue, to slow down the progression of coronary artery calcification (CAC) in this patient population. The authors investigated the effects of etidronate on CAC score in patients with end-stage renal disease. Their study aims to understand the impact of etidronate on the severity of coronary artery calcification.
Etidronate May Help Reduce Coronary Artery Calcification in Dialysis Patients
The results of this study suggest that etidronate may be beneficial in reducing the progression of coronary artery calcification in patients undergoing long-term hemodialysis. These findings are promising, given the significant health risks associated with CAC in this population. The study provides a foundation for further research into the potential benefits of etidronate as a preventative measure for cardiovascular disease in dialysis patients.
Protecting Cardiovascular Health for Dialysis Patients
This research highlights the importance of proactive measures to protect cardiovascular health in dialysis patients. Understanding the potential of etidronate and other therapies in managing CAC could lead to better treatment strategies and improved outcomes for this vulnerable patient population. It's important to consult with a doctor to discuss personalized strategies for managing cardiovascular health, especially if you are on dialysis.
Dr.Camel's Conclusion
Coronary artery calcification is like the sandstorms in the desert, slowly eroding the cardiovascular system. This research suggests that etidronate might be a shield against this erosion, offering a potential solution for dialysis patients. More research is needed to clarify the long-term effects of etidronate, but this study provides a valuable roadmap for future explorations in this critical area.
Date :
- Date Completed 2005-03-01
- Date Revised 2022-03-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.